# EDGAR Filing Document

**Accession Number:** 0002108747
**File Stem:** 0001437749-26-002722
**Filing Date:** 2026-2
**Character Count:** 9156
**Document Hash:** 6a1dffa94021c7e5174bd798a261e73d
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001437749-26-002722.hdr.sgml**: 20260203

**ACCESSION NUMBER**: 0001437749-26-002722

**CONFORMED SUBMISSION TYPE**: 3

**PUBLIC DOCUMENT COUNT**: 2

**CONFORMED PERIOD OF REPORT**: 20260101

**FILED AS OF DATE**: 20260203

**DATE AS OF CHANGE**: 20260203

**REPORTING-OWNER**: 

**OWNER DATA:**
- **COMPANY CONFORMED NAME:** LoPresto Jennifer Hayes
- **CENTRAL INDEX KEY:** 0002108747

**ORGANIZATION NAME:**

**FILING VALUES:**
- **FORM TYPE:** 3
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 000-27701
- **FILM NUMBER:** 26590182

**MAIL ADDRESS:**
- **STREET 1:** 500 11TH AVENUE NORTH, SUITE 850
- **CITY:** NASHVILLE
- **STATE:** TN
- **ZIP:** 37203
**ISSUER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** HEALTHSTREAM INC
- **CENTRAL INDEX KEY:** 0001095565
- **STANDARD INDUSTRIAL CLASSIFICATION:** SERVICES-COMPUTER PROGRAMMING, DATA PROCESSING, ETC. [7370]
- **ORGANIZATION NAME:** 06 Technology
- **EIN:** 621443555
- **STATE OF INCORPORATION:** TN
- **FISCAL YEAR END:** 1231

**BUSINESS ADDRESS:**
- **STREET 1:** 500 11TH AVENUE NORTH
- **STREET 2:** SUITE 850
- **CITY:** NASHVILLE
- **STATE:** TN
- **BUSINESS PHONE:** 6153013100

**MAIL ADDRESS:**
- **STREET 1:** 500 11TH AVENUE NORTH
- **STREET 2:** SUITE 850
- **CITY:** NASHVILLE
- **STATE:** TN

## Ex-24

```

Exhibit 24

LIMITED POWER OF ATTORNEY

KNOW ALL MEN BY THESE PRESENTS, that Jennifer H. LoPresto has made,
constituted and appointed, and by these presents does make, constitute
and appoint Scott Roberts, Amelia Emmert, and/or Tori Huger as its true
and lawful attorney-in-fact, for its and in its name, place and stead,
and for its use and benefit, to do all things and to execute all documents
necessary to ensure compliance with Section 16 reporting requirements
associated with my relationship with HealthStream, Inc.

It is my intention by this instrument to grant unto said attorney-in-fact
full power and authority to do and perform all and every act and thing
whatsoever to accomplish the foregoing grant of power as shall be necessary
to be done on my behalf as fully to all intents and purposes as I might or
could do if I was present in person.

This power of attorney may be revoked by the undersigned only by specific
revocation endorsed or written hereon, and until such revocation be endorsed
or written hereon, all persons may rely upon this power of attorney as being
in full force and effect.

IN WITNESS WHEREOF, I have hereunto set my hand, the 6th day of January, 2026.

							_/s/ Jennifer H. LoPresto__
							Jennifer H. LoPresto

```

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## FORM 3

### INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

---

| | | |
|:---|:---|:---|
| **1. Name and Address of Reporting Person**<sup>*</sup><br>LoPresto Jennifer Hayes<br><sub>(Last) (First) (Middle)</sub><br>500 11TH AVENUE NORTH<br>SUITE 850<br><sub>(Street)</sub><br>NASHVILLE, TN 37203<br><sub>(City) (State) (Zip)</sub> | **3. Issuer Name and Ticker or Trading Symbol**<br>HEALTHSTREAM INC [ HSTM ] | **5. If Amendment, Date of Original Filed (Month/Day/Year)**<br>  |
| **2. Date of Event Requiring Statement (Month/Day/Year)**<br>2026-01-01 | **4. Relationship of Reporting Person(s) to Issuer**<br>(Check all applicable)<br>[ ] Director   [ ] 10% Owner<br>[X] Officer (give title below)   [ ] Other (specify below)<br>_Senior Vice President_ | **6. Individual or Joint/Group Filing (Check Applicable Line)**<br>[X] Form filed by One Reporting Person<br>[ ] Form filed by More than One Reporting Person |

---

## Table I - Non-Derivative Securities Beneficially Owned

---

|  |  |  |  |
| --- | --- | --- | --- |
| 1. Title of Security | 2. Amount of Securities Beneficially Owned | 3. Ownership Form | 4. Nature of Indirect Beneficial Ownership |
| Common Stock Holding | 6056 | D |  |

---

## Table II - Derivative Securities Beneficially Owned

---

|  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Derivative Security | 2. Date Exercisable and Expiration Date (Month/Day/Year) | 2. Date Exercisable and Expiration Date (Month/Day/Year) | 3. Title and Amount of Underlying Securities | 3. Title and Amount of Underlying Securities | 4. Conversion or Exercise Price | 5. Ownership Form | 6. Nature of Indirect Beneficial Ownership |
| 1. Title of Derivative Security | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | 4. Conversion or Exercise Price | 5. Ownership Form | 6. Nature of Indirect Beneficial Ownership |
| Restricted Share Units | <sup>(1)</sup> | <sup>(2)</sup> | Common Stock | 449 | 0.0000<sup>(3)</sup> | D |  |
| Restricted Share Units | <sup>(4)</sup> | <sup>(2)</sup> | Common Stock | 224 | 0.0000<sup>(3)</sup> | D |  |
| Restricted Share Units | <sup>(5)</sup> | <sup>(2)</sup> | Common Stock | 371 | 0.0000<sup>(3)</sup> | D |  |
| Restricted Share Units | <sup>(6)</sup> | <sup>(2)</sup> | Common Stock | 457 | 0.0000<sup>(3)</sup> | D |  |
| Restricted Share Units | <sup>(7)</sup> | <sup>(2)</sup> | Common Stock | 476 | 0.0000<sup>(3)</sup> | D |  |
| Restricted Share Units | <sup>(8)</sup> | <sup>(2)</sup> | Common Stock | 435 | 0.0000<sup>(3)</sup> | D |  |
| Restricted Share Units | <sup>(9)</sup> | <sup>(2)</sup> | Common Stock | 2172 | 0.0000<sup>(3)</sup> | D |  |
| Restricted Share Units | <sup>(10)</sup> | <sup>(2)</sup> | Common Stock | 475 | 0.0000<sup>(3)</sup> | D |  |
| Restricted Share Units | <sup>(11)</sup> | <sup>(2)</sup> | Common Stock | 517 | 0.0000<sup>(3)</sup> | D |  |
| Restricted Share Units | <sup>(12)</sup> | <sup>(2)</sup> | Common Stock | 1880 | 0.0000<sup>(3)</sup> | D |  |
| Employee Stock Option (right to buy) | <sup>(13)</sup> | 2035-12-09 | Common Stock | 5641 | $23.9300 | D |  |

---

### Footnotes:

(1) The RSUs are subject to a vesting schedule, contingent upon continued service at the time of vesting. 449 RSUs vest on March 23, 2026.

(2) Not applicable.

(3) Each restricted share unit (RSU) represents the contingent right to receive one share of common stock upon vesting of the unit.

(4) The RSUs are subject to a vesting schedule, contingent upon continued service at the time of vesting. 224 RSUs vest on October 27, 2026.

(5) The RSUs are subject to a vesting schedule, contingent upon continued service at the time of vesting. 171 RSUs vest on March 22, 2026 and 200 RSUs vest on March 22, 2027.

(6) The RSUs are subject to a vesting schedule, contingent upon continued service at the time of vesting. 211 RSUs vest on September 20, 2026 and 246 RSUs vest on September 20, 2027.

(7) The RSUs are subject to a vesting schedule, contingent upon continued service at the time of vesting. 112 RSUs vest on March 20, 2026, 168 RSUs vest on March 20, 2027, and 196 RSUs vest on March 20, 2028.

(8) The RSUs are subject to a vesting schedule, contingent upon continued service at the time of vesting. 102 RSUs vest on September 18, 2026, 154 RSUs vest on September 18, 2027, and 179 RSUs vest on September 18, 2028.

(9) The RSUs are subject to a vesting schedule, contingent upon continued service at the time of vesting. 511 RSUs vest on November 20, 2026, 767 RSUs vest on November 20, 2027, and 894 RSUs vest on November 20, 2028.

(10) The RSUs are subject to a four year vesting schedule, contingent upon continued service at the time of vesting. 15% vest on March 19, 2026, 20% vest on March 19, 2027, 30% vest on March 19, 2028, and the remaining 35% vest on March 19, 2029.

(11) The RSUs are subject to a four year vesting schedule, contingent upon continued service at the time of vesting. 15% vest on September 24, 2026, 20% vest on September 24, 2027, 30% vest on September 24, 2028, and the remaining 35% vest on September 24, 2029.

(12) The RSUs are subject to a four year vesting schedule, contingent upon continued service at the time of vesting. 15% vest on December 9, 2026, 20% vest on December 9, 2027, 30% vest on December 9, 2028, and the remaining 35% vest on December 9, 2029.

(13) The options are subject to a four year vesting schedule, contingent upon continued service at the time of vesting. 15% vest on December 9, 2026, 20% vest on December 9, 2027, 30% vest on December 9, 2028, and the remaining 35% vest on December 9, 2029.

**Signature:** /s/ Jennifer H. LoPresto  
**Date:** 2026-02-03

### Remarks:

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

**Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.**